Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

Vasso Apostolopoulos*, Geoffrey A Pietersz, Anastasios Tsibanis, Annivas Tsikkinis, Heleni Drakaki, Bruce E Loveland, Sara J Piddlesden, Magdalena Plebanski, Dodie S Pouniotis, Michael N Alexis, Ian F McKenzie and Stamatis Vassilaros

Breast Cancer Research 2006, 8:R27 doi:10.1186/bcr1505

Accesses  

  • Last 30 days: 91 accesses
  • Last 365 days: 1126 accesses
  • All time: 6553 accesses